Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Using Shockwave technology for aortic repair procedures

Official title: International Multi-center Study to Confirm the Safety and Performance of the Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair

Run by Rede Optimus Hospitalar SA · NCT06332911 · Data updated 2026-11-12

This study is testing if a new shockwave technology can help doctors successfully access tricky blood vessels during aortic repair surgeries.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorRede Optimus Hospitalar SA
Research network
Locations5 sites (Münich, Bavaria and 4 other locations)
StatusRecruiting
StartedMay 19, 2025
Main results expectedMay 30, 2026
Study endsMay 30, 2027
Registry record updatedMay 23, 2025
Trial IDNCT06332911 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with specific types of thoracic or thoraco-abdominal aneurysms requiring endograft implantation and facing hostile iliac access.

Probably not a fit

Patients without hostile iliac access or those not requiring thoracic or thoraco-abdominal aortic repairs may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the outcomes of the Shockwave™ Peripheral Intravascular Lithotripsy Balloon in treating challenging iliac access during thoracic and thoraco-abdominal aortic repairs. It involves collecting standardized data on procedures, underlying conditions, and cardiovascular risks, along with physiological parameters measured before, during, and after surgery. Follow-up visits at 1 month, 6 months, and 12 months will assess adverse events and the success of the procedures. The study aims to analyze the technical success of accessing hostile iliac vessels using this innovative technology.

Why it matters

Potential benefit: If successful, this approach could improve access for complex aortic repairs, potentially leading to better patient outcomes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving access for complex vascular procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient (m/f) age ≥ 18 years at time of enrollment.
2. Diagnosis of thoracic and/or thoraco-abdominal (Extent I-V) and juxta/para-renal/short-neck aneurysm requiring the implantation of a thoracic and/or thoraco-abdominal fenestrated/branched aortic endograft with delivery system introducer sheath diameter equal or larger than 18 Fr (6 mm).
3. Hostile iliac access was defined in the presence of:

   * Heavily circumferential calcified iliac arteries
   * Inner diameter ≤ 6 mm
   * Severe stenosis (\> 50%; \> 2.5 m/s peak velocity; absence of triphasic duplex signal in ipsilateral common femoral artery)
4. We will accept the following presentations of aneurysm:

   * urgent cases,
   * elective,
   * symptomatic
   * and fast growing.
5. The repair was performed using Shockwave™ before the introduction of the main endograft. The iliac procedures can be accompanied by angioplasty and/or stent and stent-graft positioning.

Exclusion Criteria:

1. Patients submitted to surgical conduit bypass.
2. Not-severely calcified disease (absence of calcification).
3. In-stent restenosis/occlusion.
4. Inability to cross with 0.014 guidewire.
5. Any significant medical condition which, in the investigator's opinion, may interfere with the subject's optimal participation in the study.
6. Pre-stented iliac access vessels at the level of Shockwave implementation.

Where it's running

  • Department of Vascular Surgery, LMU Hospital Munich
    Münich, Bavaria, Germany
    Recruiting
  • Department of Vascular Surgery, Klinikum Nürnberg Campus Süd
    Nuremberg, Bavaria, Germany
    Recruiting
  • University of Genoa School of Medicine, Ospedale Policlinico San Martino - HSM
    Genoa, Liguria, Italy
    Recruiting
  • Azienda Ospedaliera Universitaria Integrata di Verona
    Verona, Veneto, Italy
    Recruiting
  • Inselspital, University Hospital Bern, Heart Vascular Center
    Bern, Canton Bern, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.